Violation Tracker Individual Record

Company: 
AstraZeneca Pharmaceuticals
Current Parent Company: 
AstraZeneca
Penalty: 
$68,500,000
Year: 
2011
Date: 
March 10, 2011
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
drug or medical equipment safety violation
Violation Description: 

AstraZeneca Pharmaceuticals agreed to pay $68.5 million to settle multistate litigation alleging unfair and deceptive practices in its marketing of the antipsychotic drug Seroquel, including promotion of the drug for unapproved uses, failure to adequately disclose potential side effects to health care providers, and withholding of scientific studies that called into question the drug's safety and efficacy.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
United Kingdom
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Link to Archived Court Document: 
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.